(Q44596246)

4 December 2017

title

Formoterol used as needed improves health-related quality of life in asthmatic patients uncontrolled with inhaled corticosteroids (English)

1 reference

4 December 2017

0 references

1 reference

2

Dirkje S Postma

1 reference

4 December 2017

Elisabeth Ståhl

1

1 reference

4 December 2017

Klas Svensson

3

1 reference

4 December 2017

Arne Eivindson

5

1 reference

4 December 2017

Ad Schreurs

6

1 reference

4 December 2017

Claes-Göran Löfdahl

7

1 reference

4 December 2017

Dirkje S. Postma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509561

14 March 2024

Anne E. Tattersfield

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509561

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14509561

14 March 2024

publication date

1 September 2003

1 reference

full work available at URL

4 December 2017

http://www.resmedjournal.com/article/S0954611103001380/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14509561

https://api.elsevier.com/content/article/PII:S0954611103001380?httpAccept=text/xml

14 March 2024

1 reference

10.1016/S0954-6111(03)00138-0

DOI

https://api.crossref.org/works/10.1016/S0954-6111(03)00138-0

https://api.elsevier.com/content/article/PII:S0954611103001380?httpAccept=text/plain

14 March 2024

1 reference

10.1016/S0954-6111(03)00138-0

DOI

https://api.crossref.org/works/10.1016/S0954-6111(03)00138-0

14 March 2024

1 reference

4 December 2017

volume

97

1 reference

4 December 2017

issue

9

1 reference

4 December 2017

page(s)

1061-1066

1 reference

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Onset and duration of action of single doses of formoterol inhaled via Turbuhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Interpreting treatment effects in randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Asthma quality of life during 1 year of treatment with budesonide with or without formoterol.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Measuring quality of life in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

Quality-of-life considerations in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2803%2900138-0

7 January 2021

10.1016/S0954-6111(03)00138-0

Identifiers

DOI

1 reference

4 December 2017

1 reference